The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Oxford GlycoSciences Plc

Oxford GlycoSciences Plc
 PROFILE
Oxford GlycoSciences uses the separation, identification, and characterization of proteins (proteomics) to develop new pharmaceuticals. Using proteomics, the firm identifies proteins that may correspond with certain diseases. The firm's lead drug candidate, Vevesca, is waiting FDA approval as a therapy for Gaucher's disease. The company also has antifungal and anticancer drugs in development. Oxford GlycoSciences has filed patents covering more than 1,500 disease-specific proteins that may have applications for such ailments as rheumatoid arthritis, breast cancer, and Alzheimer's disease. Its partners include Bayer, GlaxoSmithKline, Pfizer, Packard BioScience, and Applera.

 COMPETITION
Genzyme Corporation (GENZ)
Large Scale Biology Corporation (LSBC)
Scios Inc. (SCIO)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 13.30
1-Yr. Sales Growth: (5.2)%
Employees: 186
Revenue per employee: $71,505.38

 KEY PEOPLE
• Michael L. Kranda
    CEO
• Stephen B. Parker
    CFO

 CONTACT INFO
The Forum, 86 Milton Park
Abingdon Oxfordshire OX14 4RY, United Kingdom
Phone: 44-1235-208-000
Fax: 44-1235-208-020
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001